Search
for
Sort by
Research 751–780 of 1000+
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Finasteride
- The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population
- The investigation and management of hirsutism
- Paradoxical Effect After IPL Photoepilation
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women
- Preparation and clinical evaluation of Finastride gel in the treatment of idiopathic Hirsutism
- Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study
- Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden
- Acne-Associated Syndromes
- [Long-term treatment of virilized women with cyproterone acetate (author's transl)].
- Bilateral ovarian steroid cell tumor in a postmenopausal woman with progressive hyperandrogenism
- Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?
- A systematic review and meta-analysis on the association between androgenic alopecia and the risk of metabolic syndrome
- Association of Polycystic Ovary Syndrome (PCOS) with Acne Vulgaris: An observational&nbsp;<span style="font-size: 1rem;">study</span>
- Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Association between Polymorphisms of OCT1 and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- What does the research say about androgen use and cerebrovascular events?
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- Anthropometric Characteristics of Polycystic Ovary Syndrome and Their Associations with Insulin Resistance and Lipid Profile
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review
- Late bedtime was associated with increased androgen and reduced lean mass in women with polycystic ovary syndrome: a cross-sectional study
- Prevalence, Symptomatology and Herbal Management of Polycystic Ovarian Syndrome
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Metabolic dysfunction-associated steatotic liver disease is associated with androgenetic alopecia in adults with stronger effects in women and unhealthy lifestyles